Tickwind
TodayOpportunitiesMarketsAI Chat
EN
Log inSign up
Tickwind

Read every tick. See where the market's blowing.

  • X
  • TelegramChinese
  • Newsletter

Product

  • Markets
  • Theme Zones
  • All stocks
  • Compare
  • Hot stocks
  • Opportunities
  • News
  • Discussion
  • Watchlist
  • What's new

Account

  • Settings
  • Newsletter
  • For writers
  • MCP server
  • Contact
  • Log in
  • Sign up
MarketsTheme ZonesAll stocksCompareHot stocksOpportunitiesNewsDiscussionWatchlistWhat's newSettingsNewsletterFor writersMCP serverContactLog inSign up

© 2026 Tickwind. Not investment advice.

Made for the curious investor.

Home/SRZN/vs peers

SRZNSurrozen, Inc./DEvs its industry peers

A metric-by-metric comparison of Surrozen, Inc./DE against SIC 2836 — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.

Full peer comparison
Peers: same SEC industry
CompanyMarket capP/E (TTM)P/BP/SRevenue growth (YoY)Earnings growth (YoY)EBIT marginROEROICPiotroski F1y total returnDividend yield
SRZNSurrozen, Inc./DEThis$362M#8——104.1x#7-67.4%#7-280.8%#13-1210.6%#6———120.1%#1—
GRMLGreenland Mines Ltd$627M#1—10.8x#11——-71.6%#11—-18.2%#3-14.6%#1—-83.3%#11—
RGNXREGENXBIO Inc.$513M#2—7.2x#103.0x#2104.5%#214.6%#5-94.6%#2-270.2%#10——-32.5%#10—
EDITEditas Medicine, Inc.$416M#3—4.0x#910.3x#425.4%#332.5%#3-394.9%#5-152.0%#9——-2.2%#7—
ALLOAllogene Therapeutics, Inc.$406M#4—0.9x#2—-100.0%#825.9%#4—-43.8%#5——7.3%#5—
ZURAZura Bio Ltd$386M#5—3.8x#8——-31.0%#10—-67.6%#7——16.4%#4—
TECX$380M#6—1.7x#5——-27.9%#9—-33125.9%#11-713.5%#4———
CCCCC4 Therapeutics, Inc.$380M#7—1.5x#410.6x#51.0%#60.3%#6-320.5%#4-42.5%#4——37.3%#3—
KYTXKyverna Therapeutics, Inc.$318M#9—1.9x#6——-26.5%#8—-97.4%#8-107.1%#2—-18.6%#8—
SCTXScribe Therapeutics, Inc.$311M#12———————————
AGENAGENUS INC$312M#112.3x#2—2.7x#110.4%#498.7%#2-17.7%#1———85.8%#2—
XFORX4 Pharmaceuticals, Inc$315M#102.2x#12.0x#79.0x#31273.2%#1-111.5%#12-247.4%#3-50.9%#6-582.0%#3—-19.5%#9—
SABSSAB Biotherapeutics, Inc.$298M#1413.6x#31.4x#3—-100.0%#8138.9%#1—6.2%#1——0.6%#6—
EIKN$300M#13—0.6x#1————0.0%#2————
OCGN$289M#15——65.5x#68.8%#5-25.9%#7-1425.7%#7—————

Peer set: US filers sharing this company's SEC industry classification (SIC 2836). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. This table timed out mid-build, so it covers part of the group; ranks are within the rows shown and it fills in shortly. Table built 2026-11-04.

Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice

SRZN's peers

GRMLRGNXEDITALLOZURATECXCCCCKYTXSCTXAGENXFORSABSEIKNOCGN
← SRZN overview